ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value ($000): $413,698 (100.0% shares, 0.0% debt)

Holdings (21)

QUIDEL CORP 38.0%
Value ($000) $157,265 Shares 2,364,883 Est. Cost $25223.83 Unrealized
ACCELERATE DIAGNOSTICS INC 23.0%
Value ($000) $95,312 Shares 4,274,080 Est. Cost $22.30 Unrealized
PACB PACIFIC BIOSCIENCES CALIF IN 8.3%
Value ($000) $34,452 Shares 9,704,761 Est. Cost $4.84 Unrealized -42.7%
TESARO INC 8.2%
Value ($000) $33,954 Shares 763,535 Est. Cost $12435.97 Unrealized
OPK OPKO HEALTH INC 4.2%
Value ($000) $17,325 Shares 3,686,194 Est. Cost $7.29 Unrealized -48.0%
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 4.0%
Value ($000) $16,544 Shares 1,393,743 Est. Cost $8.65 Unrealized
AMARIN CORP PLC 3.9%
Value ($000) $16,258 Shares 5,261,338 Est. Cost $669.33 Unrealized
VERMILLION INC 1.9%
Value ($000) $7,669 Shares 9,825,289 Est. Cost $1445.80 Unrealized
BIOLASE INC 1.8%
Value ($000) $7,470 Shares 6,173,250 Est. Cost $1.21 Unrealized
CONTRAFECT CORP 1.7%
Value ($000) $7,127 Shares 3,224,733 Est. Cost $2.67 Unrealized
SOLENO THERAPEUTICS INC 1.4%
Value ($000) $5,705 Shares 2,438,060 Est. Cost $1.81 Unrealized
AGENUS INC 0.8%
Value ($000) $3,404 Shares 1,499,540 Est. Cost $2.27 Unrealized
ACCELERATE DIAGNOSTICS INC 0.5%
Value ($000) $2,106 Shares 607,600 Est. Cost $22.30 Unrealized
ADURO BIOTECH INC 0.5%
Value ($000) $2,079 Shares 297,047 Est. Cost $8.85 Unrealized
BIIB BIOGEN INC 0.4%
Value ($000) $1,848 Shares 6,368 Est. Cost $213.68 Unrealized +31.6%
ARENA PHARMACEUTICALS INC 0.4%
Value ($000) $1,739 Shares 39,887 Est. Cost $31.92 Unrealized
EPIZYME INC 0.4%
Value ($000) $1,723 Shares 127,143 Est. Cost $17.56 Unrealized
MAZOR ROBOTICS LTD 0.2%
Value ($000) $697 Shares 135,300 Est. Cost $11234.47 Unrealized
QUIDEL CORP 0.2%
Value ($000) $660 Shares 105,700 Est. Cost $25223.83 Unrealized
ARENA PHARMACEUTICALS INC 0.1%
Value ($000) $295 Shares 100,000 Est. Cost $31.92 Unrealized
TESARO INC 0.0%
Value ($000) $66 Shares 11,000 Est. Cost $12435.97 Unrealized